USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

Suppr

超能文献

出版信息

Clin Infect Dis. 1995 Aug;21 Suppl 1:S32-43.

PMID:8547510

Abstract

摘要

相似文献

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

Clin Infect Dis. 1995 Aug;21 Suppl 1:S32-43.

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

Clin Infect Dis. 1995 Aug;21 Suppl 1:S1-11.

USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: an overview. USPHS/IDSA Prevention of Opportunistic Infections Working Group.

Clin Infect Dis. 1995 Aug;21 Suppl 1:S12-31. doi: 10.1093/clinids/21.supplement_1.s12.

1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: disease-specific recommendations. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Services/Infectious Diseases Society of America.

Clin Infect Dis. 1997 Oct;25 Suppl 3:S313-35.

2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.

HIV Clin Trials. 2001 Nov-Dec;2(6):493-554. doi: 10.1310/AQML-UABK-5LLB-E615.

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.

Clin Infect Dis. 2000 Apr;30 Suppl 1:S29-65. doi: 10.1086/313848.

Preface to the 1997 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. USPHS/IDSA Prevention of Opportunistic Infections Working Group. US Public Health Service/Infectious Diseases Society of America.

Clin Infect Dis. 1997 Oct;25 Suppl 3:S299-312.

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. U.S. Public Health Service (USPHS) and Infectious Diseases Society of America (IDSA).

Infect Dis Obstet Gynecol. 2000;8(1):5-74. doi: 10.1155/S1064744900000028.

Introduction to the 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus.

Clin Infect Dis. 2000 Apr;30 Suppl 1:S1-4. doi: 10.1086/313847.

1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV: Part III. Prevention of disease recurrence. United States Public Health Service/Infectious Diseases Society of America.

Am Fam Physician. 2000 Feb 1;61(3):771-8, 780, 785.

引用本文的文献

Potential Influence of Regulation of the Food Value Chain on Prevalence and Patterns of Antimicrobial Resistance: the Case of Tilapia (Oreochromis niloticus).

Appl Environ Microbiol. 2021 Nov 10;87(23):e0094521. doi: 10.1128/AEM.00945-21. Epub 2021 Sep 22.

Immunological efficacy of pneumococcal vaccine strategies in HIV-infected adults: a randomized clinical trial.

Sci Rep. 2016 Sep 1;6:32076. doi: 10.1038/srep32076.

Pneumococcal vaccination among HIV-infected adult patients in the era of combination antiretroviral therapy.

Hum Vaccin Immunother. 2014;10(12):3700-10. doi: 10.4161/hv.32247.

Late diagnosis of HIV infection at two academic medical centers: 1994-2004.

AIDS Care. 2008 Sep;20(8):977-83. doi: 10.1080/09540120701767257.

Analysis of a population-based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease.

Am J Public Health. 2002 Mar;92(3):395-8. doi: 10.2105/ajph.92.3.395.

Primary care for patients infected with human immunodeficiency virus: a randomized controlled trial.

J Gen Intern Med. 2001 Sep;16(9):573-82. doi: 10.1046/j.1525-1497.2001.016009573.x.

Cost effectiveness of prophylaxis for opportunistic infections in AIDS. An overview and methodological discussion.

Pharmacoeconomics. 1998 Aug;14(2):165-74. doi: 10.2165/00019053-199814020-00005.

Current and emerging azole antifungal agents.

Clin Microbiol Rev. 1999 Jan;12(1):40-79. doi: 10.1128/CMR.12.1.40.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验